Work

Randomized Phase II Study of Two Schedules of Flavopiridol (Alvocidib, F) Given as Timed Sequential Therapy (TST) Wtih Ara-C and Mitoxantrone (FLAM) for Adults with Newly Diagnosed, Poor-Risk Acute Myelogenous Leukemia (AML)

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.186.186

Authors: Judith E. Karp, John M. Pagel, B. Douglas Smith, Jacqueline M Greer, D. Michelle Drye, Kelly M. Smith, Kathleen Dorcy, John J Wright, L. Austin Doyle, Elizabeth Garrett-Mayer, Elihu H. Estey

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Fred Hutch Cancer Center, Sidney Kimmel Cancer Center, University of Washington Medical Center, National Cancer Institute, Medical University of South Carolina

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2571041746

FWCI: 0.399

Cites:

Cited by: 2

Related to: 10